Cyclophosphamide-Induced Infertility and the Impact of Antioxidants

Am J Reprod Immunol. 2024 Dec;92(6):e70014. doi: 10.1111/aji.70014.

Abstract

An important drawback of anticancer chemotherapy is the harm it causes to healthy cells. Cyclophosphamide (CP) is a widely used chemotherapeutic alkylating agent that is regularly used in cancer treatment. However, it can cause severe side effects, including genotoxicity, due to its ability to damage DNA. This toxicity is thought to be associated with oxidative stress induced by an excessive amount of reactive oxygen species (ROS). Therefore, there is a specific focus on the potential effects of anticancer treatments on fertility. Due to the increasing life expectancy of cancer patients, those desiring parenthood may face the negative impacts of therapies. Utilizing substances with antioxidant and cytoprotective characteristics to protect the reproductive system from harmful consequences during chemotherapy would be highly beneficial. This review introduces the physiological and pathological roles of ROS in the reproductive systems of both males and females, then we address the adverse effects of CP administration on infertility and discuss how antioxidants can reverse these effects.

Keywords: antioxidant; chemotherapy; cyclophosphamide; infertility.

Publication types

  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents, Alkylating* / adverse effects
  • Antioxidants* / pharmacology
  • Antioxidants* / therapeutic use
  • Cyclophosphamide* / adverse effects
  • Cyclophosphamide* / therapeutic use
  • Female
  • Humans
  • Infertility / chemically induced
  • Male
  • Neoplasms / drug therapy
  • Oxidative Stress* / drug effects
  • Reactive Oxygen Species* / metabolism

Substances

  • Cyclophosphamide
  • Antioxidants
  • Reactive Oxygen Species
  • Antineoplastic Agents, Alkylating